Member Detail - DF/HCC

Dr. Mark Awad

Claim this profile

Dana Farber Cancer Institute

Studies Non-Small Cell Lung Cancer
Studies Solid Tumors
13 reported clinical trials
22 drugs studied

Area of expertise

1Non-Small Cell Lung Cancer
Mark Awad has run 9 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage IV
MET positive
Stage III
2Solid Tumors
Mark Awad has run 8 trials for Solid Tumors. Some of their research focus areas include:
Stage IV
Stage III
ROS1 positive

Affiliated Hospitals

Image of trial facility.
Dana Farber Cancer Institute
Image of trial facility.
Dana Faber Cancer Institute

Clinical Trials Mark Awad is currently running

Image of trial facility.

APL-101

for Lung Cancer

This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
Image of trial facility.

Avutometinib + Sotorasib

for Lung Cancer

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with sotorasib with or without defactinib in patients with KRAS G12C Non-Small Cell Lung Cancer (NSCLC) in patients who have been exposed to prior G12C inhibitor and those who have not been exposed to prior G12C inhibitor.
Recruiting1 award Phase 1 & 2

More about Mark Awad

Clinical Trial Related4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Mark Awad has experience with
  • Carboplatin
  • Paclitaxel
  • Cisplatin
  • Docetaxel
  • Nivolumab
  • Pemetrexed
Breakdown of trials Mark Awad has run
Non-Small Cell Lung Cancer
Solid Tumors
Lung Cancer
Uterine Tumors
Metastatic Tumor

Other Doctors you might be interested in

Sapna Syngal, MDDana Farber Cancer Center, Harvard University
Suman Srinivasa, MDMassachusetts General Hospital
Daniel C. Chung, MDMassachusetts General Hospital

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Awad specialize in?
Mark Awad focuses on Non-Small Cell Lung Cancer and Solid Tumors. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are MET positive.
Is Mark Awad currently recruiting for clinical trials?
Yes, Mark Awad is currently recruiting for 6 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Mark Awad has studied deeply?
Yes, Mark Awad has studied treatments such as Carboplatin, Paclitaxel, Cisplatin.
What is the best way to schedule an appointment with Mark Awad?
Apply for one of the trials that Mark Awad is conducting.
What is the office address of Mark Awad?
The office of Mark Awad is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top